Aged Oolong Tea Reduces High-Fat Diet-Induced Fat Accumulation and Dyslipidemia by Regulating the AMPK/ACC Signaling Pathway

Nutrients. 2018 Feb 8;10(2):187. doi: 10.3390/nu10020187.

Abstract

While oolong tea (OT) has been shown to induce weight loss and reduce fat accumulation, the mechanisms remain poorly defined, especially for aged OT. In this study, five groups of mice (n = 9/group) were used including a normal diet with vehicle treatment, and a high-fat diet (HFD) with vehicle or the water extracts from aged OTs (EAOTs, three different storage years) by oral gavage at 1000 mg/kg·BW for 6 weeks. Body weight, fat accumulation, and serum biochemical parameters were used to evaluate obesity. The morphology of hepatocytes and adipocytes was analyzed by being stained with hematoxylin and eosin. The levels of p-AMPK, p-ACC (and non-phosphorylated versions), CPT-1 and FAS were determined by Western blotting and immunohistochemistry. EAOTs decreased HFD-induced body weight, fat accumulation, serum levels of triglyceride, total cholesterol, and low-density lipoprotein cholesterol, while enhancing the serum high-density lipoprotein cholesterol level. At the same time, EAOTs clearly alleviated fatty liver and reduced the size of adipocytes in the epididymal fat, especially in the 2006 group. Most importantly, EAOTs increased the phosphorylation of AMPK and ACC, and up-regulated the expression of CPT-1 but down-regulated the expression of fatty acid synthase, TNF-α and iNOS. Thus, EAOTs may inhibit obesity by up-regulating energy expenditure and fatty acid oxidation while inhibiting fatty acid synthesis and inflammation.

Keywords: aged oolong tea; anti-inflammation; anti-obesity; water extract.

Publication types

  • Comparative Study

MeSH terms

  • Adipose Tissue, White / metabolism
  • Adipose Tissue, White / pathology
  • Animals
  • Anti-Obesity Agents / therapeutic use
  • Camellia sinensis / chemistry*
  • Diet, High-Fat / adverse effects
  • Dietary Supplements
  • Dyslipidemias / etiology
  • Dyslipidemias / metabolism
  • Dyslipidemias / pathology
  • Dyslipidemias / prevention & control*
  • Food Handling*
  • Food Storage*
  • Freeze Drying
  • Hypolipidemic Agents / therapeutic use
  • Lipotropic Agents / therapeutic use
  • Liver / metabolism
  • Liver / pathology
  • Male
  • Mice, Inbred C57BL
  • Non-alcoholic Fatty Liver Disease / etiology
  • Non-alcoholic Fatty Liver Disease / metabolism
  • Non-alcoholic Fatty Liver Disease / pathology
  • Non-alcoholic Fatty Liver Disease / prevention & control*
  • Obesity / etiology
  • Obesity / metabolism
  • Obesity / pathology
  • Obesity / prevention & control*
  • Plant Extracts / therapeutic use*
  • Plant Leaves / chemistry
  • Random Allocation
  • Signal Transduction
  • Tea

Substances

  • Anti-Obesity Agents
  • Hypolipidemic Agents
  • Lipotropic Agents
  • Plant Extracts
  • Tea